Cosmetic Pterygium Surgery: Techniques and Long-Term Outcomes

Arun C Gulani, Aaishwariya A Gulani Gulani Vision Institute, Jacksonville, FL, USACorrespondence: Arun C GulaniGulani Vision Institute, 8075 Gate Parkway West Suite 102, Jacksonville, FL 32216, USATel +1 904 296 7393Fax +1888 650-0744Email gulanivision@gulani.comBackground: To demonstrate the long-t...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Gulani AC, Gulani AA
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2020
Materias:
Acceso en línea:https://doaj.org/article/a8b8ac40c99d45afa6f45f79abc39fb9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a8b8ac40c99d45afa6f45f79abc39fb9
record_format dspace
spelling oai:doaj.org-article:a8b8ac40c99d45afa6f45f79abc39fb92021-12-02T09:33:37ZCosmetic Pterygium Surgery: Techniques and Long-Term Outcomes1177-5483https://doaj.org/article/a8b8ac40c99d45afa6f45f79abc39fb92020-06-01T00:00:00Zhttps://www.dovepress.com/cosmetic-pterygium-surgery-techniques-and-long-term-outcomes-peer-reviewed-article-OPTHhttps://doaj.org/toc/1177-5483Arun C Gulani, Aaishwariya A Gulani Gulani Vision Institute, Jacksonville, FL, USACorrespondence: Arun C GulaniGulani Vision Institute, 8075 Gate Parkway West Suite 102, Jacksonville, FL 32216, USATel +1 904 296 7393Fax +1888 650-0744Email gulanivision@gulani.comBackground: To demonstrate the long-term results of enhanced cosmetic pterygium surgery with extensive Tenonectomy, adjunctive fibrin-glued amniotic membrane transplantation (AMT), and mitomycin C (MMC).Methods: Retrospective chart review of patients who had pterygium surgery with AMT and MMC between January 2001 to July 2017 and had completed at least 6 months of follow-up. Early and long-term postoperative cosmetic outcomes, recurrence rate, and complications were analyzed. Cosmetic outcomes were evaluated based on patient and surgeon reported outcome measures.Results: The study was conducted on a total of 603 eyes of 578 patients (316 males, 262 females) with an average age of 52.9 ± 15.1 years. At post-op day 1, patients reported no discomfort and could not tell which eye had surgery based on patient reported subjective grading scales. Over an average follow-up period of 23.1 ± 35 months (range: 6– 216 months), there was one pterygium recurrence (0.2%), eighteen granulomas (2.9%), one self-resolving scleral melt (0.2%), one correctable restricted ocular motility (0.2%), one pupil abnormality (0.2%), one dellen (0.2%) and one correctable upper lid abnormality (0.2%). Planned laser vision correction was used for residual corneal scar in eleven eyes (1.8%) as a staged refractive approach.Conclusion: This study highlights an improved technique of an old concept of pterygium surgery that not only reduces the recurrence but also enhances cosmetic excellence and improves the quality of vision.Keywords: amniotic membrane, mitomycin C, pterygiumGulani ACGulani AADove Medical Pressarticleamniotic membranemitomycin cpterygiumOphthalmologyRE1-994ENClinical Ophthalmology, Vol Volume 14, Pp 1681-1687 (2020)
institution DOAJ
collection DOAJ
language EN
topic amniotic membrane
mitomycin c
pterygium
Ophthalmology
RE1-994
spellingShingle amniotic membrane
mitomycin c
pterygium
Ophthalmology
RE1-994
Gulani AC
Gulani AA
Cosmetic Pterygium Surgery: Techniques and Long-Term Outcomes
description Arun C Gulani, Aaishwariya A Gulani Gulani Vision Institute, Jacksonville, FL, USACorrespondence: Arun C GulaniGulani Vision Institute, 8075 Gate Parkway West Suite 102, Jacksonville, FL 32216, USATel +1 904 296 7393Fax +1888 650-0744Email gulanivision@gulani.comBackground: To demonstrate the long-term results of enhanced cosmetic pterygium surgery with extensive Tenonectomy, adjunctive fibrin-glued amniotic membrane transplantation (AMT), and mitomycin C (MMC).Methods: Retrospective chart review of patients who had pterygium surgery with AMT and MMC between January 2001 to July 2017 and had completed at least 6 months of follow-up. Early and long-term postoperative cosmetic outcomes, recurrence rate, and complications were analyzed. Cosmetic outcomes were evaluated based on patient and surgeon reported outcome measures.Results: The study was conducted on a total of 603 eyes of 578 patients (316 males, 262 females) with an average age of 52.9 ± 15.1 years. At post-op day 1, patients reported no discomfort and could not tell which eye had surgery based on patient reported subjective grading scales. Over an average follow-up period of 23.1 ± 35 months (range: 6– 216 months), there was one pterygium recurrence (0.2%), eighteen granulomas (2.9%), one self-resolving scleral melt (0.2%), one correctable restricted ocular motility (0.2%), one pupil abnormality (0.2%), one dellen (0.2%) and one correctable upper lid abnormality (0.2%). Planned laser vision correction was used for residual corneal scar in eleven eyes (1.8%) as a staged refractive approach.Conclusion: This study highlights an improved technique of an old concept of pterygium surgery that not only reduces the recurrence but also enhances cosmetic excellence and improves the quality of vision.Keywords: amniotic membrane, mitomycin C, pterygium
format article
author Gulani AC
Gulani AA
author_facet Gulani AC
Gulani AA
author_sort Gulani AC
title Cosmetic Pterygium Surgery: Techniques and Long-Term Outcomes
title_short Cosmetic Pterygium Surgery: Techniques and Long-Term Outcomes
title_full Cosmetic Pterygium Surgery: Techniques and Long-Term Outcomes
title_fullStr Cosmetic Pterygium Surgery: Techniques and Long-Term Outcomes
title_full_unstemmed Cosmetic Pterygium Surgery: Techniques and Long-Term Outcomes
title_sort cosmetic pterygium surgery: techniques and long-term outcomes
publisher Dove Medical Press
publishDate 2020
url https://doaj.org/article/a8b8ac40c99d45afa6f45f79abc39fb9
work_keys_str_mv AT gulaniac cosmeticpterygiumsurgerytechniquesandlongtermoutcomes
AT gulaniaa cosmeticpterygiumsurgerytechniquesandlongtermoutcomes
_version_ 1718398081305673728